Publications by authors named "Hagit Shapira"

Introduction: organ cultures (EVOC) were recently optimized to sustain cancer tissue for 5 days with its complete microenvironment. We examined the ability of an EVOC platform to predict patient response to cancer therapy.

Methods: A multicenter, prospective, single-arm observational trial.

View Article and Find Full Text PDF

Bacteria were first detected in human tumors more than 100 years ago, but the characterization of the tumor microbiome has remained challenging because of its low biomass. We undertook a comprehensive analysis of the tumor microbiome, studying 1526 tumors and their adjacent normal tissues across seven cancer types, including breast, lung, ovary, pancreas, melanoma, bone, and brain tumors. We found that each tumor type has a distinct microbiome composition and that breast cancer has a particularly rich and diverse microbiome.

View Article and Find Full Text PDF

Background: The human papillomavirus (HPV) test has proven to be efficient in triaging women with abnormal Pap findings in women with low cytological atypia, but there is no data about the accuracy for large loop excision of transformation zone in cases of recurrent atypia.

Objectives: To assess the clinical correlation between results of HPV typing and conization histology in women who had recurrent abnormal Pap test results with no colposcopy findings.

Methods: Our retrospective cohort study included 138 women enrolled in the Maccabi Healthcare Services who had consecutive atypical Pap test results for 2 years in which no abnormal colposcopic findings were detected.

View Article and Find Full Text PDF

Purpose: This study describes time trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel in the years 1986-2010 and characterizes these patients by demographics.

Methods: A retrospective survey based on cervical cancer and CIN3 data documented in the computerized system of the second largest Health Maintenance Organizations (HMO) in Israel, "Maccabi Healthcare Services" (MHS) between 1986 and 2010.

Results: 737 cervical cancer patients and 3,459 patients of CIN3 were reported between 1986 and 2010.

View Article and Find Full Text PDF

Objectives: This study aimed to assess the prevalence of human papillomavirus (HPV) in Israeli patients with cervical cancer and cervical intraepithelial neoplasia 3 (CIN3), to describe the distribution of the virus genotypes among positive cases, to characterize patients positive to HPV and, in particular, patients positive to HPV-16 and/or -18, and to evaluate the possible contribution of implementing HPV vaccination in Israel.

Methods: Samples from 84 patients with cervical cancer and 886 patients with CIN3, archived at the Maccabi Institute of Pathology, were screened for HPV. DNA extraction was performed using DNeasy Blood and Tissue Kit/QIAGEN.

View Article and Find Full Text PDF

The balance between the adhesion of cancer cells to extracellular matrix and their migratory potential, as well as their proteolytic activity, are important parameters that determine cancer cells invasiveness and metastasis. Since thrombin has been implicated in cancer progression, we studied the role(s) of thrombin-activated receptors in the adhesion process. We stably knocked down proteinase-activated receptors (PARs) -1, or -3 in human pancreatic adenocarcinoma PANC-1 cells.

View Article and Find Full Text PDF

We showed previously that proliferating human islet-derived de-differentiated cells (DIDs) exhibit many characteristics of mesenchymal stem cells. Dispersed DIDs can be induced by serum deprivation to undergo mesenchymal-to-epithelial transition and aggregate into epithelial cell clusters (ECCs). Conversely, ECCs can be induced to disperse and undergo epithelial-to-mesenchymal transition (EMT) by re-addition of mammalian sera.

View Article and Find Full Text PDF

Purpose: This study describes the distribution and the trends of cervical abnormalities in Israel, based on Pap smear results.

Methods: A retrospective analysis of cervical smears received by the Central Pathology Laboratory of Maccabi Healthcare Services between January 2005 and December 2010.

Results: In total, 711,541 Pap smears were screened in the study period.

View Article and Find Full Text PDF

Objectives: Proteinase-activated receptor-1 (PAR-1) and PAR-2 have been associated with increased invasiveness and metastasis in human malignancies. The role of PAR-3 has been less investigated. We examined the role of PARs in a human pancreatic adenocarcinoma PANC-1 cell line phenotype in vitro.

View Article and Find Full Text PDF

High levels of plasminogen activator inhibitor-1 (PAI-1), which is produced by stromal, endothelial, and cancer cells and has multiple complex effects on cancers, correlate with poor cancer prognosis. To more definitively study the role of endogenously produced PAI-1 in human pancreatic adenocarcinoma (PAC) PANC-1 cell line biology, we used anti-PAI-1 shRNA to create stable PAI-1 deficient cells (PD-PANC-1s). PD-PANC-1s exhibited a heterogeneous morphology.

View Article and Find Full Text PDF
Article Synopsis
  • Injection of antisense oligodeoxyoligonucleotides (ASODNs) targeting LPA receptors and specific G-proteins reduces the LPA response, but does not prevent the rapid desensitization effect.
  • The study suggests that different G-proteins facilitate both the activation of LPA receptors and their subsequent desensitization in Xenopus oocytes, with Ca2+ channels playing a role in the desensitization process.
View Article and Find Full Text PDF

Threshold concentrations of lysophosphatidic acid (LPA) or acetylcholine (ACh) induce pertussis toxin (PTX)-sensitive rapid desensitization of responses to LPA in Xenopus oocytes. To demonstrate that threshold [LPA] rapidly activates Gi/o proteins, we used the G protein-activated K+ channel (GIRK) as a reporter. Low [LPA] induced IK+ in <3 s of the agonist addition with little or no activation of chloride current.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Hagit Shapira"

  • - Hagit Shapira's recent research primarily focuses on cancer biology, particularly the influence of the tumor microenvironment and microbiome on treatment responses and disease progression.
  • - In her 2023 study published in *Front Med (Lausanne)*, Shapira explored an organ culture system that can predict individual patient responses to cancer therapies, while her 2020 research in *Science* identified tumor type-specific microbiome compositions in over 1,500 tumors, highlighting significant variations between different cancer types.
  • - Additional studies by Shapira address the clinical implications of HPV in cervical cancer and precancerous conditions, providing vital insights into patient demographics, HPV genotype prevalence, and trends in cervical cancer incidents in Israel, ultimately contributing to better screening and treatment strategies.